- Home
- CMPR vs OCUL Comparison
CMPR vs OCUL Comparison
Compare CMPR & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMPR | OCUL |
|---|---|---|
| Founded | 1994 | 2006 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Publishing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | 2005 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CMPR | OCUL |
|---|---|---|
| Price | $94.75 | $9.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $86.50 | $23.56 |
| AVG Volume (30 Days) | 156.2K | ★ 1.9M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 553.45 | N/A |
| EPS | ★ 3.79 | N/A |
| Revenue | ★ $3,736,643,000.00 | $1,990,000.00 |
| Revenue This Year | $10.43 | $7.93 |
| Revenue Next Year | $5.46 | $96.07 |
| P/E Ratio | $25.00 | ★ N/A |
| Revenue Growth | ★ 9.80 | 3.48 |
| 52 Week Low | $56.34 | $6.23 |
| 52 Week High | $106.58 | $16.44 |
Technical Indicators
Market Signals| Indicator | CMPR | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 44.27 | 55.55 |
| Support Level | $93.51 | $9.06 |
| Resistance Level | $96.00 | $9.27 |
| Average True Range (ATR) | 4.71 | 0.32 |
| MACD | -0.78 | 0.10 |
| Stochastic Oscillator | 57.50 | 96.54 |
Price Performance
Historical ComparisonAbout CMPR Cimpress plc (Ireland)
Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.